BiotechTube

Minocycline hydrochloride capsules

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Sep 30, 2022 → May 30, 2023

NCT ID
NCT05597462

About Minocycline hydrochloride capsules

Minocycline hydrochloride capsules is a phase 1 stage product being developed by Dr. Reddy's Laboratories for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT05597462. Target conditions include Rosacea.

What happened to similar drugs?

5 of 15 similar drugs in Rosacea were approved

Approved (5) Terminated (2) Active (8)
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
✅Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
✅Azelaic acid 15% + Brimonidine 0.33%BayerApproved
✅Azelaic Acid foam 15%BayerApproved
✅azelaic acid 15% gel + azelaic acid 15% gelBayerApproved
🔄Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT05597462Phase 1Completed

Competing Products

20 competing products in Rosacea

See all competitors
ProductCompanyStageHype Score
DFD-04 OintmentDr. Reddy's LaboratoriesPhase 2
32
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
DFD-29 Extended Release Capsules (40 mg) + DFD-29 Extended Release Capsules (20 mg) + Oraycea® (doxycycline) Capsules + Placebo CapsulesDr. Reddy's LaboratoriesPhase 2
32
DoxycyclineDr. Reddy's LaboratoriesPhase 1
26
DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3
37
Lotilaner Gel, 2.0%Tarsus PharmaceuticalsPhase 2
29
lotilaner + VehicleTarsus PharmaceuticalsPhase 2
36
DRM02Eli LillyPhase 2
35
Clascoterone Cream 1%Sun PharmaceuticalPhase 2
42
Metronidazole Topical Gel 1% + Metronidazole Topical Gel 1% (Metrogel) + PlaceboSun PharmaceuticalPhase 1
29
Azelaic Acid 15% topical gel + Finacea® (azelaic acid) Gel, 15% + PlaceboSun PharmaceuticalPhase 1
29
Azelaic acid foam 15% + Finacea® (Azelaic acid Foam) 15% + Vehicle of the test productSun PharmaceuticalPhase 1
29
Laropiprant + Placebo for LaropiprantMerckPhase 1
29
AMG 334NovartisPhase 2
31
BFH772 1% ointment + Vehicle ointment + Noritate® 1% creamNovartisPhase 2
35
Deucravacitinib + PlaceboBristol Myers SquibbPhase 2
27
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)BayerApproved
40
Coppertone, BAY1183345BayerPre-clinical
23
Azelaic acid 15% + Brimonidine 0.33%BayerApproved
40
Azelaic Acid foam 15%BayerApproved
40